Richter transformation

Last updated on: 05.11.2021

Dieser Artikel auf Deutsch

Definition
This section has been translated automatically.

Richter transformation is defined as a transformation of CLL into an aggressive lymphoma, most commonly diffuse large B-cell lymphoma. Less commonly (in about 10% of cases - Jamroziak K et al. 2015) into Hodgkin's lymphoma, referred to as Hodgkin variant Richter syndrome (HvRS).

The patients with Richter transformation usually respond poorly to conventional chemotherapy used to treat diffuse large B-cell lymphoma de novo.

Occurrence
This section has been translated automatically.

The incidence of Richter transformation is reported between 4% to 20% of previously treated CLL patients (Ding W 2018).

Clinical picture
This section has been translated automatically.

Patients show a rapid clinical deterioration. In particular, a rapid increase in B-symptomatology is observed. This is a rather rarely observed phenomenon in CLL. Furthermore, localized or generalized lymph node swelling and an increase in the LDH value are indicative.

Diagnostics
This section has been translated automatically.

Histopathological examination is a prerequisite for diagnosis. It is crucial to assess the relationship between the RS clone and the underlying CLL/SLL, as clonally related DLBCL-RS have a poor prognosis, while clonally unrelated cases have a similar prognosis to de novo DLBCL.

Therapy
This section has been translated automatically.

Immunochemotherapy based on anti-CD20 antibodies has been the first choice in the treatment of DLBCL-RS (see CLL below); however, the results are not satisfactory (Puła B et al. 2019). Younger and fit patients should be offered allogeneic stem cell transplantation as consolidation therapy.

Prognose
This section has been translated automatically.

Patients with Richter transformation have a significantly worse prognosis than most patients with CLL. This probably results from an unfavourable individual genetic mutation pattern.

Literature
This section has been translated automatically.

  1. Ding W (2018) Judge transformation in the era of novel agents. Hematology Am Soc Hematol Educ Program 2018:256-263
  2. Jamroziak K et al (2015) Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy. Leuk Lymphoma. 56:1949-1958.
  3. Puła B et al. (2019) Immunochemotherapy for Richter syndrome: current insights. Immunotargets Ther 8:1-14.

Incoming links (1)

Chronic lymphocytic leukemia;

Last updated on: 05.11.2021